Physician profile
Meghan E Leusch
NPI 1215421490
$2,079.85
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $667 · 2023: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,145.30 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $227.21 | 2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $160.35 | 2023 | Entyvio, Gattex |
| Genzyme Corporation | $100.93 | 2022 | |
| Eisai INC. | $84.99 | 2022 | |
| Janssen Biotech, INC. | $79.23 | 2023 | Stelara |
| Regeneron Healthcare Solutions, INC. | $64.48 | 2022-2023 | Dupixent |
| Ardelyx, INC. | $55.91 | 2023 | Ibsrela |
| Gilead Sciences, INC. | $52.84 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.01 | 2023 | Cyltezo |
| Celgene Corporation | $35.16 | 2023 | Zeposia |
| Astellas Pharma US INC | $17.92 | 2021 | |
| Pfizer INC. | $14.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Leusch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.